103 related articles for article (PubMed ID: 8393296)
21. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
22. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
23. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells.
Civitelli R; Kim YS; Gunsten SL; Fujimori A; Huskey M; Avioli LV; Hruska KA
Endocrinology; 1990 Nov; 127(5):2253-62. PubMed ID: 2226314
[TBL] [Abstract][Full Text] [Related]
24. Increased vitamin D receptor level enhances 1,25-dihydroxyvitamin D3-mediated gene expression and calcium transport in Caco-2 cells.
Shao A; Wood RJ; Fleet JC
J Bone Miner Res; 2001 Apr; 16(4):615-24. PubMed ID: 11315989
[TBL] [Abstract][Full Text] [Related]
25. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
26. Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness.
Reinhardt TA; Horst RL
J Biol Chem; 1989 Sep; 264(27):15917-21. PubMed ID: 2550427
[TBL] [Abstract][Full Text] [Related]
27. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
28. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
29. Disassociation of the macrophage-maturational effects of vitamin D from respiratory burst priming.
Tanaka H; Hruska KA; Seino Y; Malone JD; Nishii Y; Teitelbaum SL
J Biol Chem; 1991 Jun; 266(17):10888-92. PubMed ID: 1645714
[TBL] [Abstract][Full Text] [Related]
30. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
31. Association of 1 alpha,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites.
Kim YS; MacDonald PN; Dedhar S; Hruska KA
Endocrinology; 1996 Sep; 137(9):3649-58. PubMed ID: 8756529
[TBL] [Abstract][Full Text] [Related]
32. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
Farach-Carson MC; Sergeev I; Norman AW
Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
[TBL] [Abstract][Full Text] [Related]
33. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
[TBL] [Abstract][Full Text] [Related]
34. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
36. Identification of a competitive binding component in vitamin D-resistant New World primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D3.
Gacad MA; Adams JS
J Bone Miner Res; 1993 Jan; 8(1):27-35. PubMed ID: 8381251
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells.
Friedman PA; Gesek FA
Am J Physiol; 1993 Aug; 265(2 Pt 2):F300-8. PubMed ID: 8368339
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
[TBL] [Abstract][Full Text] [Related]
40. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]